CFM
EVH icon

Catalyst Funds Management’s Evolent Health EVH Stock Holding History

Catalyst Funds Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,200
Closed -$33.9K – 641
2024
Q3 		$33.9K Buy
+1,200
New +$30.9K 0.01% 933

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Catalyst Funds Management's EVH Position: Q4 2024 in Review

Catalyst Funds Management sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 1,200 shares — an estimated $33.9K sold.

Catalyst Funds Management first reported a position in EVH in Q3 2024 and held it in 1 quarter. The position peaked at $33.9K in Q3 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Catalyst Funds Management reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 1,200 Evolent Health shares in Q4 2024, an estimated $33.9K.
  • Catalyst Funds Management first reported a position in Evolent Health in Q3 2024 and held it in 1 quarter.
  • Catalyst Funds Management's Evolent Health position peaked at $33.9K in Q3 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.